Ramanjaneya et al 2021

Obesity and insulin resistance are key elements of the metabolic syndrome. C1Q Tumor necrosis factor-related proteins (CTRPs) have recently emerged as important regulators of metabolism as a core component in the interrelationship between insulin resistance, adiposity and inflammation.

Pharmacological intervention and lifestyle modification alter expression of CTRPs in circulation and in metabolically active tissues. CTRPs enhance metabolism and possess insulin sensitizing properties; thus, dysregulated expression of CTRPs in metabolic disorders could contribute to the pathogenesis of the disease. For these reasons, CTRPs appear to be promising targets for early detection, prevention and treatment of metabolic disorders.

In this review article, Ramanjaneya and colleagues explore the role of CTRPs in the metbaolic system.

Authors: Hamid Reza Kouhpayeh, Farhad Tabasi, Mohammad Dehvari, Mohammad Naderi, Gholamreza Bahari, Tahereh Khalili, Courtney Clark, Saeid Ghavami and Mohsen Taheri

Content type: Research

17 November 2021

Authors: Yendry Ventura-Carmenate, Fatima Mohammed Alkaabi, Yandy Marx Castillo-Aleman, Carlos Agustin Villegas-Valverde, Yasmine Maher Ahmed, Pierdanilo Sanna, Ayesha Abdulla Almarzooqi, Abeer Abdelrazik, Gina Marcela Torres-Zambrano, Maura Wade-Mateo, David Quesada-Saliba, Loubna Abdel Hadi, Antonio Alfonso Bencomo-Hernandez and Rene Antonio Rivero-Jimenez

Content type: Research

3 November 2021

Authors: Mandana Mohyeddin Bonab, Fatemeh Talebian, Aida Borzabadi, Vahideh Nasr, Azam Abedi Kooshlshahi, Fahime Anisie, Ronaz Haghshenas, Bita Shalbafan, Ehsan Janzamin and Saeed Shahbeigi

Content type: Research

19 October 2021

Authors: Ersilio Trapanese and Giulio Tarro

Content type: Research

18 October 2021

Authors: Srikanth Umakanthan, Sanjum Senthil, Stanley John, Mahesh K. Madhavan, Jessica Das, Sonal Patil, Ragunath Rameshwaram, Ananya Cintham, Venkatesh Subramaniam, Madhusudan Yogi, Abhishek Bansal, Sumesh Achutham, Chandini Shekar, Vijay Murthy and Robbin Selvaraj

Content type: Research

25 September 2021

Most recent articles RSS

View all articles

Authors: Attila A. Seyhan

Content type: Review

18 November 2019

Authors: Kishalay Paria, Debarati Paul, Trinath Chowdhury, Smritikana Pyne, Ranadhir Chakraborty and Santi M. Mandal

Content type: Review

5 November 2020

Authors: Dolores Margarita Rodr铆guez, Mery Elizabeth Guerrero, B谩rbara Marisol Maldonado, Claudia Vollbracht and Sandra Aracely Herrera

Content type: Research

10 March 2017

Authors: Mahmood Y. Hachim, Ibrahim Y. Hachim, Kashif Bin Naeem, Haifa Hannawi, Issa Al Salmi and Suad Hannawi

Content type: Research

9 September 2020

Authors: Payam Peymani, Tania Dehesh, Farnaz Aligolighasemabadi, Mohammadamin Sadeghdoust, Katarzyna Kotfis, Mazaher Ahmadi, Parvaneh Mehrbod, Pooya Iranpour, Sanaz Dastghaib, Ahmad Nasimian, Amir Ravandi, Biniam Kidane, Naseer Ahmed, Pawan Sharma, Shahla Shojaei, Kamran Bagheri Lankarani

Content type: Research

25 January 2021

Most accessed articles RSS

View all articles

漏 enotmaks / Fotolia

Translational Medicine Communications is an interdisciplinary forum for all scientifically valid research from across translational medicine. We publish research that focuses on the biology of disease, as well as preclinical and basic research that is closely associated with medicine. Translational Medicine Communications will also consider reviews, methodology articles, protocols and commentaries.
聽
Our aim is to improve transparency and reproducibility within translational medicine, which is why we consider research papers regardless of outcome or significance of findings, as well as protocols for future research. We aim to serve the translational science community by publishing all scientifically valid and technically sound articles and we are dedicated to facilitating the communication between basic and clinical science.

Translational Medicine Communications is the companion journal to Journal of Translational Medicine.

Journal of Translational Medicineconsiders articles focusing on information derived from human experimentation to optimise the communication between basic and clinical science.

Explore the companion journal

Dr. Marincola is Global Head of Research at Kite Pharma, Santa Monica, California. He was previously President and Chief Scientific Officer at Refuge Biotechnologies, Menlo Park, California, Distinguished Research Fellow at AbbVie Corporation; Chief Research Officer at Sidra Research, Qatar; and Tenured Investigator at the National Institutes of Health, Maryland. Dr. Marincola founded in 2003 the Journal of Translational Medicine and is the Editor-in-Chief. He is also Editor-in-Chief of Translational Medicine Communications. He is past-president of the Society for the Immunotherapy of Cancer (SITC) and the International Society for Translational Medicine. He edited several books including the SITC-affiliated Cancer Immunotherapy Principles and Practice Textbook. Dr. Marincola is also an award winning fiction author of The Wise Men of Pizzo and Cat Behind the Window.

Advertisement